RK

Ramanjaneya Hanumanthappa Katta - Profile

Ramanjaneya Hanumanthappa Katta, Managing Director and Designated Partner, with 5 companies.

About Ramanjaneya Hanumanthappa Katta

Ramanjaneya Hanumanthappa Katta has 21 years in corporate governance. Holds Managing Director and Designated Partner roles. Currently with 3 companies, including Smo Clinical Research (India) Private Limited and Indya Clinical Research Private Limited. Formerly with 2 companies, such as Clintrac International Private Limited and Equitorial Investments Private Limited. Engaged in General Business, Technology.

Current Companies 3
Past Companies 2
Total Affiliations 5
Oldest Company Age 18
Companies Associated with Ramanjaneya Hanumanthappa Katta
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Ramanjaneya Hanumanthappa Katta?

Ramanjaneya Hanumanthappa Katta has 21 years in corporate governance. Holds Managing Director and Designated Partner roles. Currently with 3 companies, including Smo Clinical Research (India) Private Limited and Indya Clinical Research Private Limited. Formerly with 2 companies, such as Clintrac International Private Limited and Equitorial Investments Private Limited. Engaged in General Business, Technology.

What is Ramanjaneya Hanumanthappa Katta's role in current companies?

Ramanjaneya Hanumanthappa Katta is associated with 3 companies as Managing Director and Designated Partner.

What industries does Ramanjaneya Hanumanthappa Katta specialize in?

Ramanjaneya Hanumanthappa Katta has expertise in General Business, Technology.

How many years of experience does Ramanjaneya Hanumanthappa Katta have?

Ramanjaneya Hanumanthappa Katta has 21 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available